A new class-action lawsuit in Washington state is seeking to force the state Medicaid officials to alter and revoke a policy which limits high-priced hepatitis C drugs to only the sickest patients. The complaint argues that it is unlawful to withhold prescription medication from patients solely based on cost. Read more about the lawsuit here.
Last Updated on May 8, 2020 by Aimed Alliance
